Certified by Founder Lodge
Colossal Biosciences
United Kingdom - Dallas, Texas,
START UP
1 Disclosed Funding Rounds $60,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
The science of genetics. The business of discovery.
Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genom
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 09 ,2022 | Series A | $60,000,000 | |
| February, 02 ,2023 | Series B | $150,000,000 | |
| January, 16 ,2025 | Series C | $200,000,000.00 |
Animoca Brands
BOLD Capital Partners
Builders VC
OneVentures
ARCH Venture Partners
Draper Associates
JAZZ Venture Partners
Boost VC
Untamed Planet
Animal Capital
Green Sands Equity
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)